| Literature DB >> 18157131 |
Hui-Chen Hsu1, PingAr Yang, John Wang, Qi Wu, Riley Myers, Jian Chen, John Yi, Tanja Guentert, Albert Tousson, Andrea L Stanus, Thuc-vy L Le, Robin G Lorenz, Hui Xu, Jay K Kolls, Robert H Carter, David D Chaplin, Robert W Williams, John D Mountz.
Abstract
Interleukin 17 (IL-17) is a cytokine associated with inflammation, autoimmunity and defense against some bacteria. Here we show that IL-17 can promote autoimmune disease through a mechanism distinct from its proinflammatory effects. As compared with wild-type mice, autoimmune BXD2 mice express more IL-17 and show spontaneous development of germinal centers (GCs) before they increase production of pathogenic autoantibodies. We show that blocking IL-17 signaling disrupts CD4+ T cell and B cell interactions required for the formation of GCs and that mice lacking the IL-17 receptor have reduced GC B cell development and humoral responses. Production of IL-17 correlates with upregulated expression of the genes Rgs13 and Rgs16, which encode regulators of G-protein signaling, and results in suppression of the B cell chemotactic response to the chemokine CXCL12. These findings suggest a mechanism by which IL-17 drives autoimmune responses by promoting the formation of spontaneous GCs.Entities:
Mesh:
Substances:
Year: 2007 PMID: 18157131 DOI: 10.1038/ni1552
Source DB: PubMed Journal: Nat Immunol ISSN: 1529-2908 Impact factor: 25.606